SEC Filings TLDR

On October 24, 2025, DraftKings Inc. (DKNG) granted 7,575 restricted stock units (RSUs) to Gregory Westin Wendt, a director of the company. Each RSU represents a contingent right to receive one share of the company's Class A Common Stock. The RSUs were granted as part of the initial annual equity grant and will vest in...

David Chene, a Manager of Kennedy Lewis Investment Holdings II LLC, resigned from the Board of Directors of Douglas Elliman Inc. on October 24, 2025. This resignation led to the other reporting persons no longer being deemed directors by deputization. On the same date, Douglas Elliman Inc. repurchased Senior Secured Co...

On October 27, 2025, William O'Dowd IV, the Chief Executive Officer of Dolphin Entertainment, Inc., purchased 3,000 shares of the company's common stock at a weighted average price of $1.64 per share. This transaction increased his total direct ownership to 390,788 shares. Additionally, O'Dowd indirectly owns 54,535 sh...

Jeffrey Scott Jacobs, Head of Accounting & Financial Reporting at Dayforce, Inc., sold 353 shares of common stock on October 27, 2025, at a price of $68.54 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on November 27, 2024. Following the sale, Jacobs owns 49,401 shares, including 29,...

On October 24, 2025, Samer Alkharrat, EVP and Chief Revenue Officer of Dayforce, Inc., sold 3,233 shares of common stock at a price of $68.55 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on December 5, 2024. Following the sale, Alkharrat owns 117,934 shares, which include 90,723 unv...

On October 24, 2025, T. Rowe Price Associates, Inc. sold 2,977 shares of Dayforce, Inc. common stock at a weighted average price of $68.5 per share. The transaction reduced their holdings to 24,789,870 shares. The shares were held indirectly through investment companies and institutional accounts managed by T. Rowe Pri...

Jennifer M. Fritzsche, a director of Dycom Industries Inc, acquired 44 shares of common stock on October 27, 2025, at a price of $284.16 per share. Following this transaction, her total ownership in the company increased to 9,661 shares. The transaction was reported in a Form 4 filing with the SEC, indicating a direct ...

On October 27, 2025, Philip R. Gallagher, a director of Dycom Industries Inc., acquired 52 additional shares of the company's common stock at a price of $284.16 per share. This transaction increased his total holdings to 433 shares. The acquisition was reported in a Form 4 filing with the SEC, indicating a direct owner...

On October 24, 2025, Euan Ashley, a director of DexCom Inc., was granted 7,166 restricted stock units (RSUs) in the company. These RSUs are exempt from Section 16b-3 and will vest in three equal annual installments starting from the grant date. Each RSU represents a contingent right to receive one share of DexCom Inc. ...

On October 27, 2025, Ray L. Mays, EVP & Chief Operating Officer of Dawson Geophysical Co., acquired 100,000 restricted stock units (RSUs) under the company's Amended and Restated 2016 Stock and Performance Incentive Plan. These RSUs represent the contingent right to receive shares of the company's Class A common stock ...

On October 27, 2025, William Anthony Clark, the CEO and President of Dawson Geophysical Company, received 150,000 restricted stock units (RSUs) under the Amended and Restated Dawson Geophysical Company 2016 Stock and Performance Incentive Plan. Each RSU represents the contingent right to receive one share of the compan...

Sameer K. Gandhi, a director of CrowdStrike Holdings, Inc., reported the sale of Class A common stock on October 24, 2025. The transactions were executed under a 10b5-1 plan adopted on June 27, 2025. Gandhi sold a total of 5,186 shares at weighted average prices ranging from $525.38 to $534.80 per share. Following thes...

Jeffrey G. Korn, the Chief Executive Officer of Crexendo, Inc., reported several transactions involving the company's common stock and restricted stock units (RSUs) on October 25, 2025. Korn acquired 278 and 277 shares of common stock through RSUs, with no purchase price, and disposed of 68 shares at $6.40 per share to...

The filing details the stock transactions of Douglas Walter Gaylor, the Chief Operating Officer of Crexendo, Inc. On October 25, 2025, Gaylor acquired 278 and 277 shares of common stock through the vesting of Restricted Stock Units (RSUs). These RSUs vest in equal monthly installments over 36 months, starting on March ...

Vincent Ron, the Chief Financial Officer of Crexendo, Inc., reported several transactions involving the company's common stock and restricted stock units (RSUs) on October 25, 2025. Ron acquired 278 and 277 shares of common stock at $0 per share, increasing his total holdings to 190,684 and 190,885 shares, respectively...

On October 27, 2025, June Ann Seymour, the Chief Accounting Officer of Cartesian Therapeutics, Inc., was granted 50,000 employee stock options. These options, which are rights to buy common stock, have an exercise price of $8.85 and expire on October 27, 2035. The options vest in four equal annual installments, startin...

Matthew K. Szot, the Chief Financial Officer of Cadrenal Therapeutics, Inc., sold 1,800 shares of the company's common stock on October 24, 2025, and another 1,800 shares on October 27, 2025, at a price of $13.99 per share. These sales were conducted in accordance with a Rule 10b5-1 trading arrangement adopted by Szot ...

Quang Pham, the CEO and Chairman of Cadrenal Therapeutics, Inc., sold shares of the company's common stock on October 24 and October 27, 2025, under a Rule 10b5-1 trading arrangement. The transactions involved the sale of 1,129 shares at a weighted average price of $14.03 and 1,315 shares at a weighted average price of...

On October 24, 2025, Brad Williams, President of Cadre Holdings, Inc., sold 4,132 shares of the company's common stock at a price of $43 per share. This transaction was executed under a Rule 10b5-1 trading plan, which was adopted on May 14, 2025. Following the sale, Williams retains ownership of 106,089 shares of Cadre...

On October 24, 2025, Valiyaveettil Ravi Mohan, the Chief Technology Officer of Credit Acceptance Corp, disposed of 1,269.5 shares of common stock at a price of $506.56 per share. This transaction was related to the vesting and settlement of restricted stock units, with shares withheld to satisfy tax withholding obligat...

Stephen A. Skaggs, a director of Coherent Corp., sold 2,000 shares of common stock on October 24, 2025, at a price of $130.00 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted by Skaggs on November 21, 2024. Following the sale, Skaggs owns 24,108 shares of Coherent Corp. common stock. Th...

On October 24, 2025, Monica Howard Douglas, Executive Vice President of Coca-Cola Co., engaged in several transactions involving the company's common stock. Douglas acquired 5,435 shares at $43.515 per share and 8,113 shares at $40.89 per share, increasing her holdings to 43,160 and 51,273 shares respectively. She also...

On October 27, 2025, Aunoy Banerjee, the Chief Financial Officer of Citizens Financial Group, Inc., was awarded 67,424 shares of common stock under the Amended and Restated Citizens Financial Group, Inc. 2014 Omnibus Incentive Plan. The shares were granted at a price of $0.00 per share, and following this transaction, ...

On October 28, 2025, Rick D. Day, a director of Business First Bancshares, Inc., acquired 1,600 shares of common stock at a price of $24.21 per share. Following this transaction, Day owns a total of 265,885 shares of the company's common stock. The transaction was reported in a Form 4 filing with the SEC. Additionally,...

Shawn P. McLaughlin, a director of Burke & Herbert Financial Services Corp., purchased 1,000 shares of common stock on October 28, 2025, at a price of $61 per share. Following this transaction, McLaughlin directly owns 67,000 shares. Additionally, McLaughlin has granted a Power of Attorney to several individuals, inclu...